Looks like someone is getting some Lucky Socks!

Congratulations, You should receive your package soon!
Until then, share some Lucky Socks love with your friends – you could win even more!

[facebook-page href="https://facebook.com/kindredbio" width="485" height="400" tabs="timeline" show_cta="false" small_header="false" align="left" hide_cover="false" show_facepile="true"]

News

  • Kindred Biosciences Announces Half-Life Extension Technology for Canine AntibodiesJanuary 8, 2020 - 4:04 pm
  • Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in DogsDecember 16, 2019 - 8:04 am
  • Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight LossDecember 12, 2019 - 9:09 am

Events

  • Event: Kindred Biosciences to Present at Stifel Healthcare ConferenceNovember 14, 2019 - 4:11 pm
  • Event: Kindred Biosciences to Participate at Jefferies London Healthcare ConferenceNovember 14, 2019 - 4:11 pm
  • Event: Kindred Biosciences to Announce Third Quarter 2019 Financial ResultsOctober 28, 2019 - 8:35 am
$9.50 Stock is Down -0.16 (-1.66%)
KIN (Common Stock)
Previous Close Volume
$9.66 89,150
Intraday High Intraday Low
$9.83 $9.35
52 Week High 52 Week Low
$11.35 $5.96
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

© Copyright 2012-2019 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010 | Privacy Policy| Website Terms of Use| Forward Looking Statements
Scroll to top